Company news

Generate Biomedicines, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Generate Biomedicines to Participate in November Investor Conferences

October 22, 2026

Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases

October 13, 2026

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

October 1, 2026

Generate Biomedicines Inc. to Participate in September Investor Conferences

September 8, 2026

Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

August 6, 2026

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

May 28, 2026

Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

May 7, 2026

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

February 26, 2026

Decks